US equities |
MU $1,088.00 ▲+4.06% NVDA $237.47 ▼-0.74% SNDK $1,692.42 ▲+1.92% SPCX $167.60 ▼-2.51% AMD $645.86 ▼-0.55% AAPL $336.67 ▲+0.91% TSLA $377.81 ▼-0.75% META $721.31 ▼-2.38%
FinancialContent

Latest News about Asthma

Recent news which mentions Asthma

First World Chronic Cough Day October 15, 2024
Tags United States Cough Asthma
From PRLog
Vapotherm's Asthma Therapy More Effective Than Standard Oxygen Therapy In Kids
Tickers VAPO
Tags General Briefs News
From Benzinga
Amgen's Tezspire Reduces Annualized Exacerbation Rate In Severe Asthma Patients
Tickers AMGN
Tags asthma Market News Biotech
From Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
Tickers REGN SNY
Tags REGN Briefs General
From Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
Tickers LBPS
Tags General Phase 2 Trial Movers
From Benzinga
Equillium To Reassess Potential For Its Asthma Trials
Tickers EQ
Tags EQ Movers General
From Benzinga
AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
Tickers AMGN AZN AZNCF
Tags General AMGN asthma
From Benzinga
Why Are Theravance Bio Shares Plummeting Premarket Today?
Tickers GSK TBPH VTRS
Tags Movers VTRS Small Cap
From Benzinga
AstraZeneca's Two Asthma Trials Meet Primary Endpoints
Tickers AZN RPRX
Tags General Health Care Phase 3 Trial
From Benzinga
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
Tickers AMGN AZN AZNCF
Tags General AMGN Health Care
From Benzinga
Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA
Tickers AMGN AZN
Tags General AMGN asthma
From Benzinga